American Society for Transplantation and Cellular Therapy to present several awards
Click Here to Manage Email Alerts
Several clinicians will be honored at this year’s Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, scheduled for Feb. 15-19 in Orlando.
Fred Appelbaum, MD, will receive the 2023 ASTCT Lifetime Achievement Award.
Applebaum — executive vice president of Fred Hutchinson Cancer Center and co-leader of the institution’s program in hematologic malignancies — has spent most of his career focused on development of therapies for lymphoma, leukemia and other blood cancers.
He served as lead author on the first publication to demonstrate the efficacy of cryopreserved autologous bone marrow transplantation for individuals with lymphoma. He also has helped develop novel nontransplant therapies for hematologic malignancies.
The 2022 ASTCT Public Service Award will recognize the dedication and resilience of physicians, nurses, pharmacists and advanced practice practitioners in Ukraine who continue to serve patients with blood disorders amid the war in their country.
Sergiy Klymenko, MD, PhD, and Sybiryna Korenkova, MD, will accept this award on behalf of all Ukrainian medical professionals.
Leslie Kean, MD, PhD, will deliver the E. Donnall Thomas Lecture, awarded to an individual who has made considerable contributions to the advancement of knowledge in blood and marrow transplantation.
Kean is director of the stem cell transplant center at Dana-Farber/Boston Children's Cancer and Blood Disorders Center, as well as professor of pediatrics at Harvard Medical School.
Kean’s lecture will be titled “Targeting GVHD: From the bench, to the bedside, to the FDA.” She will discuss her lab’s work to improve hematopoietic cell transplantation by understanding the molecular drivers of alloreactivity and controlling these pathways in hopes of inducing immune tolerance after transplant.
Click Here to Manage Email Alerts